Our results also demonstrated that the expression of RARRES2 in GBM was positively correlated with TME scores and M0 macrophage infiltration and positively correlated with the expression of immune checkpoints, such as PD-L1 (CD274). Here, RARRES2 is linked to glioblastoma.